
Online Psychedelic Shop

Price range: $18.00 through $950.00
2CB is a synthetic psychedelic substance belonging to the 2C family of phenethylamines. Its scientific name is 2-(4-bromo-2,5-dimethoxyphenyl)ethanamine. The compound is known for producing changes in perception, sensory processing, mood, and cognition.
2C-B has attracted attention in scientific, historical, and drug-policy discussions because it combines psychedelic properties with effects that can differ from more familiar substances such as LSD or psilocybin.
Despite its sometimes colorful presentation and reputation as a recreational psychedelic, 2C-B is a psychoactive substance that can produce unpredictable psychological and physical effects. Research into its pharmacology and long-term effects remains comparatively limited.
2C-B is a synthetic psychedelic compound in the 2C family of substituted phenethylamines. It was first synthesized in the 1970s by chemist Alexander Shulgin, who later documented the compound and related substances in his research writings.
The compound primarily affects serotonin signaling in the brain. Its activity at serotonin receptors contributes to alterations in perception, cognition, mood, and sensory processing.
Because 2C-B is not an approved medication for routine medical use, information about its effects and risks comes from pharmacological research, observational reports, toxicology information, and other forms of scientific literature.
The name 2C-B comes from the naming system used for a family of psychedelic phenethylamines.
The “2C” designation refers to two carbon atoms between the aromatic ring and the amino group, while the “B” refers to the bromine substitution on the aromatic ring.
Its full chemical name is 2-(4-bromo-2,5-dimethoxyphenyl)ethanamine.
2C-B was synthesized in 1974 by Alexander Shulgin, a chemist known for investigating psychoactive phenethylamines.
Shulgin described 2C-B and related compounds in his book PiHKAL: A Chemical Love Story, which documented the chemistry and subjective reports associated with numerous phenethylamines.
Over subsequent decades, 2C-B became known outside scientific settings and appeared in recreational drug markets.
Its legal status has subsequently been restricted in numerous countries.
Alexander Shulgin is generally credited with first synthesizing 2C-B in 1974.
Shulgin’s work involved the synthesis and investigation of numerous psychoactive compounds. His research contributed substantially to modern knowledge of the 2C family.
Historical accounts of 2C-B should be distinguished from modern clinical research because much of the early information came from self-experimentation and observational reports rather than contemporary controlled clinical trials.
2C-B primarily interacts with serotonin receptors in the central nervous system.
Psychedelic effects are strongly associated with activity at the 5-HT2A serotonin receptor, although 2C-B interacts with several receptor systems and its complete pharmacological profile is more complex.
Changes in serotonin signaling can alter how the brain processes sensory information and how a person experiences perception, emotion, and cognition.
The exact relationship between receptor activity and the full subjective experience of 2C-B remains an area of scientific interest.
2C-B changes signaling involving serotonin and other neurotransmitter systems.
These changes can influence:
Individual responses can differ considerably. Psychological state, environment, other substances, and individual biology can all influence the experience.
Serotonin receptors play an important role in psychedelic drug effects.
2C-B has activity at several serotonin receptor subtypes, including 5-HT2A receptors. Activation of these receptors is associated with changes in cortical information processing and perception.
However, receptor activity alone cannot predict exactly how an individual will respond.
Yes. 2C-B is generally classified as a psychedelic or hallucinogenic substance.
It can alter visual perception, sensory experiences, thought patterns, and emotional responses.
Its effects can overlap with those associated with other psychedelics, but its pharmacology and subjective effects are not identical to those of LSD or psilocybin.
2C-B belongs pharmacologically to the psychedelic phenethylamine family rather than being classified simply as a conventional stimulant.
Nevertheless, some people can experience increased energy, alertness, physical activation, or cardiovascular stimulation.
These effects can vary substantially between individuals and circumstances.
2C-B shares some characteristics with classical psychedelics but has its own chemical structure and pharmacological profile.
Its effects may include visual changes, altered sensory perception, emotional changes, and cognitive alterations.
Comparisons with other psychedelics should therefore be viewed as broad pharmacological descriptions rather than indications that the substances are interchangeable.
Both 2C-B and LSD can produce psychedelic effects involving altered perception and visual experiences.
However, they are chemically different substances that interact with the nervous system in different ways.
Their subjective effects, duration, intensity, and risks can vary, and individual experiences cannot reliably be predicted from a comparison between the two.
Psilocybin is a naturally occurring psychedelic compound found in certain fungi, while 2C-B is a synthetic phenethylamine.
Both can affect serotonin signaling and produce altered perception.
Their chemical structures, pharmacology, duration, and subjective effects differ.
2C-B and MDMA are chemically distinct substances.
MDMA is commonly classified as an entactogen or empathogen with stimulant properties, while 2C-B is primarily considered a psychedelic.
Both can affect serotonin and other neurotransmitter systems, but their pharmacological profiles and risks are not identical.
Reported effects can include:
Effects can vary substantially and may become uncomfortable or medically concerning.
Psychological effects can include changes in mood, perception, thought patterns, and emotional awareness.
Some people may experience positive or neutral psychological changes, while others may experience anxiety, fear, confusion, paranoia, or panic.
A person’s mental state before exposure can influence how psychedelic effects are experienced.
Potential physical effects can include:
Severe or rapidly worsening physical symptoms warrant medical attention.
2C-B can alter visual perception.
Reported visual changes may include intensified colors, geometric patterns, movement of stationary objects, changes in depth perception, and other distortions.
The intensity and character of these effects vary from person to person.
2C-B may affect multiple sensory systems.
Music, colors, textures, lighting, touch, and spatial perception can seem different during the experience.
Because perception can be significantly altered, impaired judgment and reduced awareness of environmental hazards are important safety considerations.
The duration of effects varies according to individual factors and the particular circumstances of exposure.
Factors can include metabolism, the actual composition of the substance, other substances present, and individual sensitivity.
Illicit products can create additional uncertainty because the substance sold as 2C-B may not actually contain the expected compound.
Factors that can influence effects include:
This variability is one reason generalized descriptions should not be interpreted as guarantees of a particular experience.
Potential unwanted effects can include:
The severity of effects can vary considerably.
Although serious toxicity may be uncommon relative to some substances, 2C-B is not risk-free.
Potential risks include psychological distress, cardiovascular effects, accidents caused by altered perception, interactions with other substances, and exposure to incorrectly identified or contaminated products.
The limited amount of high-quality human research also means that some long-term questions remain unresolved.
Psychedelic substances can produce intense emotional reactions.
Someone experiencing anxiety before or during exposure may experience increased fear, panic, or distress.
Severe anxiety accompanied by confusion, dangerous behavior, or physical symptoms may require professional assistance.
A psychedelic experience can become psychologically overwhelming.
Panic may involve intense fear, rapid breathing, confusion, agitation, or a feeling of losing control.
If someone becomes severely distressed or poses a danger to themselves or others, emergency assistance should be considered.
Altered perception can affect judgment and the ability to interpret surroundings accurately.
Severe confusion, inability to remain conscious, seizures, or significant behavioral changes should not simply be assumed to be ordinary psychedelic effects.
Such symptoms warrant urgent medical evaluation.
2C-B can produce cardiovascular stimulation in some individuals.
People with cardiovascular conditions may face additional concerns.
Chest pain, severe palpitations, fainting, or difficulty breathing require urgent medical attention.
Psychoactive substances can cause changes in blood pressure.
The significance of these changes depends on the individual and the presence of other medical conditions or substances.
Severe headache, chest pain, fainting, neurological symptoms, or significant confusion require medical assessment.
Changes in body temperature can occur with psychoactive substances.
A dangerously elevated temperature is an emergency, particularly when accompanied by confusion, rigidity, seizures, or loss of consciousness.
Nausea can occur with psychedelic substances.
Persistent or severe vomiting can create risks of dehydration and aspiration and should be evaluated when significant or accompanied by other concerning symptoms.
Headache can occur during or after exposure to psychoactive substances.
Severe, sudden, or unusual headaches—particularly when accompanied by neurological symptoms—should receive medical evaluation.
Psychedelics can produce intense psychological experiences.
People with certain psychiatric conditions may require particular caution because psychoactive substances can potentially worsen anxiety, paranoia, confusion, or other symptoms.
Anyone with concerns about mental health and psychedelic exposure should discuss them with a qualified healthcare professional.
2C-B can produce substantial changes in perception, including visual phenomena that may be described as hallucinations.
The experience varies considerably between individuals.
Severe confusion or persistent perceptual disturbances after the expected effects have ended warrant professional evaluation.
Yes. A difficult or distressing psychological reaction is possible.
Anxiety, panic, paranoia, confusion, and overwhelming sensory experiences can occur.
If someone is severely distressed, confused, aggressive, unconscious, or otherwise unsafe, emergency medical assistance may be necessary.
Serotonin syndrome involves excessive serotonergic activity and can be life-threatening.
The risk can be particularly concerning when serotonergic substances are combined.
Potential symptoms include agitation, confusion, sweating, fever, tremor, muscle rigidity, abnormal reflexes, and rapid changes in heart rate or blood pressure.
Severe symptoms require emergency medical treatment.
The interaction profile of 2C-B is not fully characterized.
Potentially concerning combinations include other psychoactive substances and medications that affect serotonin, cardiovascular function, or central nervous system activity.
Because the evidence base is limited, combining substances can create unpredictable risks.
Some antidepressants affect serotonin and other neurotransmitter systems.
The consequences of combining these medicines with 2C-B may depend on the specific medication and individual circumstances.
Anyone taking antidepressants should consult a healthcare professional rather than assuming that combining them with 2C-B is safe.
Monoamine oxidase inhibitors, or MAOIs, can significantly alter neurotransmitter metabolism.
Combining MAOIs with psychoactive substances can produce potentially serious interactions.
People prescribed an MAOI should consult their prescribing clinician or pharmacist before using any psychoactive substance.
Combining 2C-B with stimulants may increase cardiovascular and neurological stimulation.
Potential concerns include increased heart rate, elevated blood pressure, agitation, overheating, and anxiety.
Because illicit substances may contain unexpected compounds, the actual interaction risk may be impossible to determine from a label alone.
2C-B and MDMA affect overlapping neurotransmitter systems but have different pharmacological profiles.
Combining psychoactive substances can increase unpredictability and may increase psychological, cardiovascular, or temperature-related risks.
There is insufficient evidence to establish such combinations as safe.
Alcohol can impair judgment and coordination and may complicate the psychological effects of a psychedelic.
Combining substances can make it harder to recognize or respond appropriately to an adverse reaction.
Combining 2C-B with other psychedelics can make effects less predictable.
Interactions may increase psychological intensity or produce unexpected physical effects.
There is limited clinical evidence establishing the safety of such combinations.
Different substances can interact in ways that are difficult to predict.
Potential concerns include:
Unknown product contents make these risks even more difficult to assess.
Products sold as 2C-B may not necessarily contain 2C-B.
Misidentified or adulterated substances can expose people to unexpected compounds with different effects and toxicity profiles.
Packaging, logos, color, tablet shape, or other visual characteristics cannot reliably establish chemical identity.
Correct identification matters because different psychoactive substances can have very different pharmacological effects and medical risks.
Laboratory analytical methods are more reliable than appearance, taste, or informal assumptions.
When an adverse reaction occurs, healthcare professionals should be told what substance was reportedly taken and whether other substances may have been involved.
Illicit drug markets can involve counterfeit products, inaccurate labels, and variable concentrations.
A product described as 2C-B could potentially contain another compound or a mixture of substances.
This uncertainty is an important safety consideration when evaluating information about 2C-B products.
No.
Color, shape, markings, packaging, and flavor cannot reliably confirm chemical composition.
Analytical testing is required to establish the identity and concentration of a substance with much greater confidence.
Important warning signs include:
These symptoms warrant urgent medical evaluation.
A severe toxic reaction may involve profound confusion, loss of consciousness, seizures, dangerous cardiovascular changes, or extreme temperature abnormalities.
If a serious reaction is suspected, contact local emergency medical services immediately.
If someone becomes seriously ill after suspected 2C-B exposure:
Do not delay medical treatment while attempting to identify the substance from appearance alone.
Emergency assistance is appropriate when someone experiences:
Prompt professional assessment can be critical in serious poisoning or drug reactions.
Underlying medical conditions can affect the risks associated with psychoactive substances.
Cardiovascular conditions, neurological disorders, psychiatric conditions, and other health issues may be relevant.
People with existing medical conditions should discuss potential risks with a qualified healthcare professional.
There is insufficient evidence to establish the safety of 2C-B during pregnancy.
Because exposure to psychoactive substances during pregnancy can raise important health concerns, anyone who is pregnant or planning pregnancy should consult a healthcare professional.
Prescription medications can interact with psychoactive substances through effects on neurotransmitters, blood pressure, heart rate, metabolism, and other biological systems.
Anyone taking prescription medication should discuss potential interactions with a doctor or pharmacist.
The long-term effects of 2C-B are not as well established as those of many widely studied medicines and substances.
Research is limited, particularly regarding repeated exposure over long periods.
Consequently, absence of evidence for a particular long-term harm should not automatically be interpreted as evidence that the risk does not exist.
Scientific research has examined 2C-B’s chemistry, receptor activity, pharmacology, and reported subjective effects.
Compared with substances such as LSD, psilocybin, and MDMA, the clinical research base remains relatively limited.
Much of the available information comes from laboratory studies, observational research, toxicology reports, and historical documentation.
Current understanding indicates that 2C-B is a serotonergic psychedelic with activity at multiple receptor systems.
Its effects involve complex interactions between neurotransmitter signaling and individual psychological and physiological factors.
Researchers continue to investigate its pharmacological properties and potential risks.
Several limitations affect the available evidence.
These include relatively small human studies, inconsistent illicit-product composition, limited long-term research, and difficulty separating 2C-B effects from those of other substances that may be used at the same time.
Research findings should therefore be interpreted cautiously.
2C-B is not generally considered to have the same dependence profile as substances such as opioids or certain sedative drugs.
However, that does not mean repeated use is risk-free.
Psychological patterns of substance use can develop with many psychoactive substances, and individual responses vary.
Evidence for physical dependence associated with 2C-B is limited.
However, repeated psychoactive substance use can still create behavioral or psychological problems.
Anyone concerned about substance use should speak with a healthcare professional or qualified addiction-support service.
Tolerance refers to reduced effects after repeated exposure.
The tolerance profile of 2C-B is not fully established, and individual responses can vary.
Repeated exposure should not be assumed to be harmless simply because tolerance or withdrawal differs from other drug classes.
2C-B is a controlled substance or prohibited substance in numerous jurisdictions.
Its legal status varies by country and may change over time.
Anyone researching the legal position of 2C-B should consult current official laws applicable to their location.
Drug laws differ considerably between jurisdictions.
Some countries specifically list 2C-B as a controlled substance, while others regulate it under broader categories of psychoactive compounds.
Current government or legislative sources should be consulted for jurisdiction-specific information.
Depending on the jurisdiction, laws may restrict possession, manufacture, distribution, importation, or sale of 2C-B.
Legal consequences vary by location.
Information about another country’s drug laws should not be assumed to apply locally.
Countries use different legal frameworks for controlling psychoactive substances.
Some classify individual compounds specifically, while others use broader analogue or psychoactive-substance legislation.
Legal classifications can also change as governments update controlled-substance schedules.
Researchers can investigate 2C-B using laboratory pharmacology, receptor-binding studies, analytical chemistry, toxicology, and controlled observational research.
Analytical techniques can help determine whether a sample actually contains 2C-B and identify additional compounds.
Analytical testing is particularly important because substances sold illicitly may be mislabeled.
Laboratories can use techniques such as chromatography and mass spectrometry to identify chemical compounds.
These methods provide substantially more reliable information about composition than appearance or packaging.
2C-B is a synthetic psychedelic phenethylamine known scientifically as 2-(4-bromo-2,5-dimethoxyphenyl)ethanamine.
It can alter perception, sensory processing, mood, cognition, and visual experiences through effects on serotonin and other neurotransmitter systems.
Yes. It is generally classified as a psychedelic substance.
2C-B interacts with several serotonin receptors, including 5-HT2A, producing changes in sensory and cognitive processing.
Effects may include altered visual perception, changes in mood and sensory processing, altered time perception, and changes in thought patterns.
Duration varies depending on individual and product-related factors, and the contents of illicit products may not be reliable.
Potential adverse effects include anxiety, nausea, dizziness, headache, increased heart rate, blood-pressure changes, muscle tension, and confusion.
2C-B can produce potentially serious psychological and physical reactions, particularly when products are misidentified or combined with other substances.
Yes. Psychedelic experiences can sometimes produce significant anxiety, panic, fear, or confusion.
2C-B can substantially alter visual and sensory perception and may produce effects described as hallucinations.
Potential interactions are possible, particularly with medications affecting serotonin. Anyone taking antidepressants should consult a healthcare professional.
Combining psychoactive substances can increase unpredictability and impair judgment. Alcohol can also complicate recognition of adverse effects.
Because 2C-B affects serotonin signaling, combinations with other serotonergic substances may raise concerns about excessive serotonergic activity.
2C-B does not appear to have the same physical dependence profile as some highly dependence-producing drugs, but problematic patterns of psychoactive substance use can still occur.
Long-term human research is limited, so the complete long-term risk profile is not established.
Seizures, severe confusion, loss of consciousness, difficulty breathing, chest pain, extreme overheating, and rapidly worsening symptoms are important warning signs.
Contact local emergency medical services and provide responders with accurate information about the suspected substance and any other substances involved.
Its legal status varies by jurisdiction, and it is controlled or prohibited in numerous countries.
Both are psychedelic substances, but they have different chemical structures, pharmacological profiles, and effects.
2C-B is primarily classified as a psychedelic, whereas MDMA is generally classified as an entactogen/empathogen with stimulant properties. Their pharmacology and risks differ.
2C-B, 2C-T-7, 7th Heaven, 7-Up, Beautiful, Blue Mystic, Lucky 7, Tripstasy
What is 2cb drug?
These “club drugs” are psychoactive or hallucinogenic compounds similar to mescaline. Chemically, 2C-B is 4-bromo-2, 5-dimethoxyhenethylamine. 2C-T-7 is 2,5-dimethoxy-4-(n) ropylthiophenethylamine.2cb sale
Both are sold in powder or in pill form.2cb, 2cb drug,2c-b, blue meth, how much is a gram of cocaine
Taken orally or snorted. Even small doses can be deadly. 2C-B / 2C-T-7 is more lethal when snorted.2cb drug
What do young people hear about it?2cb sale
Young people hear that 2C-B/2C-T-7 cause psychedelic hallucinations.2cb online
Because 2C-B/2C-T-7 pills are produced in secret laboratories, they are rarely pure and the amount in a capsule or tablet is likely to vary considerably. Intense hallucinations as well as the side effects listed below can cause significant harm, particularly when taken in high doses. Additionally, 2C-B / 2C-T-7 becomes much more dangerous when combined with other substances, and could cause death.2cb drug
2cb,2cb drug,2c-b,blue meth, how much is a gram of cocaine.2,5-dimethoxy-4-bromophenethylamine (2C-B) is a psychedelic phenylethylamine derivative, structurally similar to mescaline. It is a serotonin 5-hydroxytryptamine-2A (5-HT2A), buy 2cb online,2cb online ,buy 2cb5-hydroxytryptamine-2B (5-HT2B), and 5-hydroxytryptamine-2C (5-HT2C) receptor partial agonist used recreationally as a new psychoactive substance.2cb drug
It has been reported that 2C-B induces mild psychedelic effects, although its acute pharmacological effects and pharmacokinetics have not yet been fully studied in humans. An observational study was conducted to assess the acute subjective and physiological effects, as well as pharmacokinetics of 2C-B. 2cb,2cb drug,2c-b,blue meth, how much is a gram of cocaine
Sixteen healthy, experienced drug users self-administered an oral dose of 2C-B (10, 15, or 20 mg). Vital signs (blood pressure and heart rate) were measured at baseline 1, 2, 3, 4, and 6 hours (h).2cb drug. Each participant completed subjective effects using three rating scales: the visual analog scale (VAS), the Addiction Research Centre Inventory (ARCI), and the Evaluation of the Subjective Effects of Substances with Abuse Potential (VESSPA-SSE) at baseline, 2–3 and 6 h after self-administration (maximum effects along 6 h), and the Hallucinogenic Rating Scale (maximum effects along 6 h).
Oral fluid (saliva) was collected to assess 2C-B and cortisol concentrations during 24 h. Acute administration of 2C-B increased blood pressure and heart rate. Scores of scales related to euphoria increased (high, liking, and stimulated), and changes in perceptions (distances, colors, shapes, and lights) and different body feelings/surrounding were produced. Mild hallucinating effects were described in five subjects.2cb sale
Maximum concentrations of 2C-B and cortisol were reached at 1 and 3 h after self-administration, respectively. Oral 2C-B at recreational doses induces a constellation of psychedelic/psychostimulant-like effects similar to those associated with serotonin-acting drugs.2cb drug, buy 2cb online,2cb online, buy 2cb

2C-B is a synthetic psychedelic compound belonging to the 2C family of phenethylamines. It primarily affects serotonin signaling and can produce substantial changes in perception, mood, sensory processing, and cognition.
The scientific literature on 2C-B is considerably smaller than the evidence base for several more extensively studied psychoactive substances. This creates important uncertainty regarding some aspects of its long-term effects and interactions.
Unknown or illicitly sold products introduce additional concerns because their identity, concentration, and purity may not be reliably established.
Anyone researching 2C-B should distinguish established pharmacological information from anecdotal reports and recognize the warning signs of serious toxicity. Severe overheating, seizures, loss of consciousness, breathing difficulties, chest pain, extreme confusion, or rapidly worsening symptoms require urgent medical attention.
This article is intended for educational and informational purposes. It does not recommend the use, possession, manufacture, distribution, or purchase of 2C-B.
| QUANTITY | 10 Grams, 20 Grams, 50 Grams, 100 Grams, 250 Grams, 500 Grams |
|---|
Reviews
There are no reviews yet.